Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3449]
News [8383]
Articles [66]
Editorials [9]
Conferences [223]
elearning [56]
HER2-targeted CAR T-cell therapy safe and showing promising antitumour activity...
Prof Shoba Navai - Baylor College of Medicine, Houston, USA
HER2-targeted CAR T-cell therapy safe and showing promising antitumour activity in patients with advanced sarcoma ( Prof Shoba Navai - Baylor College of Medicine, Houston, USA )
11 Apr 2019
Cancer preventive vaccine showed promising results in preclinical model of...
Prof Steven Lipkin - Weill Cornell Medical College, New York, USA
Cancer preventive vaccine showed promising results in preclinical model of Lynch syndrome ( Prof Steven Lipkin - Weill Cornell Medical College, New York, USA )
11 Apr 2019
Umbralisib shows early promise for patients with marginal zone lymphoma
Prof Nathan Fowler - MD Anderson Cancer Center, Houston, USA
Umbralisib shows early promise for patients with marginal zone lymphoma ( Prof Nathan Fowler - MD Anderson Cancer Center, Houston, USA )
11 Apr 2019
Gilteritinib improved survival for patients with acute myeloid leukaemia
Prof Alexander Perl - University of Pennsylvania, Philadelphia, USA
Gilteritinib improved survival for patients with acute myeloid leukaemia ( Prof Alexander Perl - University of Pennsylvania, Philadelphia, USA )
11 Apr 2019
Latest updates in melanoma research
Dr Alexander van Akkooi - The Netherlands Cancer Institute, Amsterdam...
Latest updates in melanoma research ( Dr Alexander van Akkooi - The Netherlands Cancer Institute, Amsterdam, Netherlands )
21 Mar 2019
Latest from CheckMate 650: Nivolumab plus ipilimumab for the treatment of...
Dr Sumit Subudhi - MD Anderson Cancer Center, Houston, USA
Latest from CheckMate 650: Nivolumab plus ipilimumab for the treatment of metastatic castration-resistant prostate cancer ( Dr Sumit Subudhi - MD Anderson Cancer Center, Houston, USA )
19 Feb 2019
STREAM trial: Enzalutamide and androgen deprivation therapy with salvage...
Prof Andrew Armstrong - Duke Cancer Institute, Durham, USA
STREAM trial: Enzalutamide and androgen deprivation therapy with salvage radiation in men with high-risk PSA recurrent PC ( Prof Andrew Armstrong - Duke Cancer Institute, Durham, USA )
15 Feb 2019
KEYNOTE-426: Pembrolizumab and axitinib vs sunitinib in advanced renal cell...
Prof Brian Rini - Cleveland Clinic, Cleveland, USA
KEYNOTE-426: Pembrolizumab and axitinib vs sunitinib in advanced renal cell carcinoma ( Prof Brian Rini - Cleveland Clinic, Cleveland, USA )
14 Feb 2019
ASCO GU 2019 renal highlights
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
ASCO GU 2019 renal highlights ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
14 Feb 2019
Latest from Tivo-3: Tivozanib for refractory advanced renal cell carcinoma
Prof Brian Rini - Cleveland Clinic, Cleveland, USA
Latest from Tivo-3: Tivozanib for refractory advanced renal cell carcinoma ( Prof Brian Rini - Cleveland Clinic, Cleveland, USA )
14 Feb 2019
Sacituzumab govitecan in patients with previously treated metastatic urothelial...
Dr Scott Tagawa - Weill Cornell Medicine, New York City, USA
Sacituzumab govitecan in patients with previously treated metastatic urothelial cancer ( Dr Scott Tagawa - Weill Cornell Medicine, New York City, USA )
14 Feb 2019
Whole genome and transcriptome analysis of metastatic adrenocortical carcinoma
Dr Jean-Michel Lavoie - BC Cancer, Vancouver, Canada
Whole genome and transcriptome analysis of metastatic adrenocortical carcinoma ( Dr Jean-Michel Lavoie - BC Cancer, Vancouver, Canada )
14 Feb 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation